TerminatedPhase 3NCT01751802

Ecopipam Treatment of Self-Injurious Behavior in Subjects With Lesch-Nyhan Disease

Studying Disorder of purine metabolism

Last synced from ClinicalTrials.gov May 8, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Emalex Biosciences Inc.
Principal Investigator: H J Jinnah, MD
Emory University
Intervention: Ecopipam(drug)
Enrollment: 9 enrolled
Eligibility: 6-70 years · All sexes
Timeline: 2012 – 2014

Study locations (2)

H.J. Jinnah, Atlanta, Georgia, United States
Hospital Universitario La Paz, Madrid, Spain

Collaborators

Psyadon Pharma

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01751802 on ClinicalTrials.gov

Other trials for Disorder of purine metabolism

Additional recruiting or active studies for the same condition.

RECRUITINGEARLY PHASE1NCT06612411
B.Subtilis Attenuate Symptoms in Diarrhea-predominant Irritable Bowel Syndrome by Increasing Hypoxanthine Biosynthesis
Jinling Hospital, China

See all trials for Disorder of purine metabolism →

← Back to all trials